Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | AMG 509 |
| Trade Name | |
| Synonyms | AMG509|AMG-509|Xaluritamig |
| Drug Descriptions |
AMG 509 is a bispecific T-cell engager targeting STEAP1 and CD3, potentially resulting in increased immune response against STEAP1-expressing tumors cells (PMID: 37861452). |
| DrugClasses | CD3 Antibody 119 |
| CAS Registry Number | NA |
| NCIT ID | C168580 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Abiraterone + AMG 509 | AMG 509 Abiraterone | 0 | 3 |
| AMG 509 | AMG 509 | 0 | 4 |
| AMG 509 + Darolutamide | AMG 509 Darolutamide | 0 | 1 |
| AMG 509 + Dexamethasone | AMG 509 Dexamethasone | 0 | 0 |
| AMG 509 + Enzalutamide | AMG 509 Enzalutamide | 0 | 1 |